LONG-ACTING FORMULATIONS OF INSULIN GLARGINE

The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.

Bibliographische Detailangaben

Hauptverfasser:	Isabell Schoettle, Katrin Tertsch, Reinhard Becker, Petra Loos, Annke Frick, Ulrich Werner, Christiane Fuerst, Peter Boderke, Werner Mueller
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!